doi: 10.1007/978-3-662-08456-4_10.
Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients
- PMID: 50710
- DOI: 10.1007/978-3-662-08456-4_10
Item in Clipboard
Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients
Acta Neuropathol Suppl.
1975.
Abstract
The specific lymphocyte sensitization of patients with malignant diseases against a basic protein, isolated from human brain, was studied by the lymphocyte migration inhibition technique. A sensitization of lymphocytes of cancer patients against this encephalitogenic factor (EF) was first reported by FIELD and CASPARY in 1970. Their test system was the Macrophage-Electrophoretic-Mobility-Test (MEMT). In 17 out of 18 patients with malignant disease we found a specific inhibition or enhancement of the migration area of lymphocytes more than 15%.
Similar articles
-
Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.Br J Cancer. 1978 Jan;37(1):15-22. doi: 10.1038/bjc.1978.2. Br J Cancer. 1978. PMID: 74259 Free PMC article.
-
Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.Br J Cancer. 1975 May;31(5):528-34. doi: 10.1038/bjc.1975.93. Br J Cancer. 1975. PMID: 50855 Free PMC article.
-
Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.Gan. 1977 Aug;68(4):449-57. Gan. 1977. PMID: 80343 No abstract available.
-
[The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].Vopr Onkol. 1972;18(6):91-6. Vopr Onkol. 1972. PMID: 4559304 Review. Russian. No abstract available.
-
Application of migration inhibition techniques in tumor immunology.Adv Cancer Res. 1985;43:241-305. doi: 10.1016/s0065-230x(08)60948-3. Adv Cancer Res. 1985. PMID: 2986429 Review. No abstract available.